Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue:    
Revenues $ 16,299 $ 12,829
Cost of revenue 5,008 3,709
Gross profit 11,291 9,120
Research and development costs 8,985 4,686
Sales and marketing expenses 6,919 5,384
General and administrative expenses 8,761 5,270
Operating loss (13,374) (6,220)
Other income (expense):    
Other (expense) income, net (63) 882
Interest expense, net (973) (1,444)
Net loss $ (14,410) $ (6,782)
Net loss per share attributable to common stockholders:    
Basic and diluted (in usd per share) $ (0.69) $ (0.43)
Weighted average shares outstanding:    
Basic and diluted (in shares) 20,734,236 15,849,667
Product revenue    
Revenue:    
Revenues $ 11,913 $ 8,832
Service and other revenue    
Revenue:    
Revenues $ 4,386 $ 3,997